• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

josepht@unimelb.edu.au

Credentials


Position
Honorary (Professorial Fellow)
Department of Microbiology and Immunology
Education
PhD
University of Melbourne
Bachelors Degree
University of Melbourne
Bachelors Degree
University of Melbourne
ORCID

0000-0002-8212-0887

Prof Joseph Torresi

Honorary (Professorial Fellow)
Department of Microbiology and Immunology

280 Scholarly works
33 Projects

HIGHLIGHTS

  • 2026

    Journal article

    Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
    DOI: 10.1038/s41541-025-01355-y
  • 2025

    Journal article

    Air–Liquid-Interface-Differentiated Human Nose Epithelium: The Benchmark Culture Model for SARS-CoV-2 Infection
    DOI: 10.3390/organoids4030021
  • 2025

    Journal article

    Spectroscopic Characterization and Differentiation of SARS-CoV-2 Virus-like Particles
    DOI: 10.1021/acs.analchem.5c01859
  • 2025

    Journal article

    Adenovirus vectors can infect mouse megakaryocytes – implications for vaccine-induced thrombosis/thrombocytopenia
    DOI: 10.1016/j.rpth.2025.102909
  • 2021

    Research Grant

    AdaptiVax-CoV: A Novel Adaptable SARS-CoV2 VLP Vaccine to Produce Broad Humoral and T Cell Responses to S, E and M Viral Proteins
  • 2020

    Research Grant

    Jack Ma Foundation Grant COVID-19 (1B)
  • 2017

    Research Grant

    Developing a Quadrivalent HCV Vaccine
Joseph Torresi

Latest Honours,
Awards and Fellowships


1995
Fellow of the Royal Australasian College of Physicians (FRACP)

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale
    DOI: 10.1002/bit.28937
  • 2025

    Book Chapter

    A Robust Human Liver Organoid Model of Hepatitis B Virus Infection
    DOI: 10.1007/7651_2025_626
  • 2024

    Journal article

    Immune imprinting of SARS-CoV-2 responses: changing first immune impressions
    DOI: 10.1128/msphere.00758-23
  • 2024

    Journal article

    Human Nasal Epithelium Organoids for Assessing Neutralizing Antibodies to a Protective SARS-CoV-2 Virus-like Particle Vaccine
    DOI: 10.3390/organoids3010002
  • 2023

    Journal article

    Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster
    DOI: 10.1016/j.ebiom.2023.104878
  • 2023

    Journal article

    Adenovirus vector produced Zika virus-like particles induce a long-lived neutralising antibody response in mice
    DOI: 10.1016/j.vaccine.2023.06.068

RECENT PROJECTS

  • 2023

    Research Contracts

    Development of Quality Target Product Profile and Review of Quality Documentation
  • 2020

    Research Contracts

    Test Biological Mechanisms of Various Therapeutics Against Respiratory Microbial Agents

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224